Starting
Initialising…
0%
TSC1
Final classification
Likely Benign
TSC1 c.2194C>T · p.His732Tyr
TSC1

NM_000368.5:c.2194C>T (p.His732Tyr) is a missense variant in TSC1, a gene in which loss-of-function variants cause tuberous sclerosis complex (autosomal dominant).

Gene
TSC1
Transcript
NM_000368.5
HGVS · transcript:coding
NM_000368.5:c.2194C>T
Consequence
N/A
GRCh38
chr9:132903665 G>A
GRCh37
chr9:135779052 G>A
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: BS1 strong, BP4 supporting benign, BP6 supporting benign; combination = 1 strong benign + 2 supporting benign, which maps to Likely Benign.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: BS1 strong, BP4 supporting benign, BP6 supporting benign; combination = 1 strong benign + 2 supporting benign, which maps to Likely Benign.
Classification rationale
BS1BP4BP6 Likely Benign
TSC1 c.2194C>T

NM_000368.5:c.2194C>T (p.His732Tyr) is a missense variant in TSC1, a gene in which loss-of-function variants cause tuberous sclerosis complex (autosomal dominant). The variant is present in gnomAD v2.1 at an allele frequency of 0.387% (1093/282512 alleles) with 7 homozygotes, and in gnomAD v4.1 at 0.360% (5806/1612416 alleles) with 28 homozygotes. This frequency exceeds the 0.3% threshold for BS1 (strong benign).1 The presence of 28 homozygous individuals in gnomAD v4.1 is incompatible with a highly penetrant autosomal dominant tumor suppressor disorder; homozygous loss of TSC1 function would be expected to cause severe disease.2 Multiple in silico predictors support a benign interpretation: REVEL score 0.338 (below 0.5 pathogenic threshold), BayesDel score -0.064 (negative score), and SpliceAI max delta 0.09 (below 0.2 splicing threshold), meeting BP4 (supporting benign).3 In ClinVar, 23 clinical laboratories classify this variant as Benign and 4 as Likely benign (Variation ID: 5103), meeting BP6 (supporting benign).4 PMID:19918125 (Lugnier et al. 2009) characterized hamartin H732Y in vitro and demonstrated reduced tuberin binding (2.3-fold, p<0.05) and aberrant nuclear localization. However, the paper explicitly reported the allele at 0.5% frequency in the normal population and concluded it 'cannot be sufficient to cause TSC or FCD,' describing it as a low-penetrance predisposing variant at most.5 Applying generic ACMG/AMP 2015 combination rules (PMID:25741868): one strong benign criterion (BS1) plus two supporting benign criteria (BP4, BP6) yields a final classification of Likely Benign.6

BS1 + BP4 + BP6 Likely Benign
3 revelbayesdelspliceai ↗
6 generic_acmg_combination_rules
Gene diagram · NM_000368.5 · variants mapped to exon structure
TSC1 NM_000368.5
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports benign
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 0.00360081; MAF= 0.36008%, 5806/1612416 alleles, homozygotes = 28) and has highest observed frequency in the European (Finnish) population (AF= 0.0139934; MAF= 1.39934%, 896/64030 alleles, homozygotes = 11); grpmax FAF= 0.00382016.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 0.00386886; MAF= 0.38689%, 1093/282512 alleles, homozygotes = 7) and has highest observed frequency in the European (Finnish) population (AF= 0.0138159; MAF= 1.38159%, 347/25116 alleles, homozygotes = 3); grpmax FAF= 0.00616893.
      🇨🇦 CA
      This variant is present in gnomAD-Canada v1.0 (AF= 0.002062975027144408, 38/18420 alleles, homozygotes = 0).
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.36% · 5806 / 1,612,416
      28 hom · FAF 0.38%
      European (Finnish)
      896 / 64,030
      1.4%
      11 hom
      European (non-Finnish)
      4619 / 1,179,952
      0.39%
      16 hom
      Remaining individuals
      183 / 62,348
      0.29%
      1 hom
      Admixed American
      66 / 60,028
      0.11%
      African/African American
      40 / 74,996
      0.053%
      Ashkenazi Jewish
      1 / 29,604
      0.0034%
      South Asian
      1 / 91,000
      0.0011%
      + 3 not observed (Amish, East Asian, Middle Eastern)
      gnomAD v2.1
      0.39% · 1093 / 282,512
      7 hom · FAF 0.62%
      European (Finnish)
      347 / 25,116
      1.4%
      3 hom
      European (non-Finnish)
      650 / 128,862
      0.5%
      4 hom
      Remaining individuals
      32 / 7,210
      0.44%
      Admixed American
      43 / 35,436
      0.12%
      African/African American
      21 / 24,964
      0.084%
      + 3 not observed (Ashkenazi Jewish, East Asian, South Asian)
      gnomAD Canada 🇨🇦
      0.21% · 38 / 18,420
      0 hom · FAF 0.22%
      European (non-Finnish)
      35 / 11,742
      0.3%
      African/African American
      2 / 1,020
      0.2%
      Remaining individuals
      1 / 1,138
      0.088%
      + 6 not observed (Latino/Admixed American, Ashkenazi Jewish, East Asian, European (Finnish), Middle Eastern, South Asian)
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Benign (23 clinical laboratories) and as Likely benign (4 clinical laboratories). (ClinVarID = 5103)
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.09). REVEL score = 0.338. BayesDel score = -0.0641334.
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. TSC1, a scaffold protein, is frequently altered by mutation in bladder cancer.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV104404438, n = 6 times).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Literature · how each cited paper was used
      1papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why. 9 further PMIDs triaged but not cited — see Sources & References.
      Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
      Found
      gnomAD v2.1 AF=0.387% with 7 homozygotes gnomAD v4.1 AF=0.360% with 28 homozygotes PMID:19918125 reports 0.5% in normal population and explicitly states variant cannot cause TSC
      Applied to
      BS1 supports · met
      Sources & reference links
      8Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      gnomAD-Canada
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots
      Triaged references · 9 PMIDs not cited in assessment
      10227394 ↗ Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. CLINVAR
      21309039 ↗ Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex. CLINVAR
      23514105 ↗ Lack of association of rare functional variants in TSC1/TSC2 genes with autism spectrum disorder. CLINVAR
      24033266 ↗ A systematic approach to assessing the clinical significance of genetic variants. CLINVAR
      25741868 ↗ Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. CLINVAR
      26467025 ↗ A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders. CLINVAR
      27425891 ↗ Minute amounts of hamartin wildtype rescue the emergence of tuber-like lesions in conditional Tsc1 ablated mice. CLINVAR
      18414213 ↗ ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. CLINVAR
      28492532 ↗ Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. CLINVAR